Twitter Feed

As Cancer Immunotherapy Month continues, make sure you catch up on our #immunotherapy fact of the day: #CIM17

.@mbklusas discusses 3 different paradigms of #cancer treatment over last 100+ years & how #Immunotherapy may be the most exciting to date.

Great article on need for better #cancer infrastructure - including clinical trials.

OmniSeq announces the New York State CLEP approval of Immune Report Card, the company's first #immunotherapy assay.

BIG news out of #Buffalo to announce tomorrow. Stay tuned for an important step forward for #Immunotherapy #cancer diagnostics.

#CancerImmunotherapyMonth is underway! Check out all our blogs on this exciting, innovative treatment: